跳至主要内容
临床试验/NCT06616168
NCT06616168进行中(未招募)1 期

Ministry of Health of Ukraine No. 2264 from 15.12.2022, Ministry of Health of Ukraine No. 310 from 08.05.2014, Ministry of Health of Ukraine No. 928 from 18.05.2023

Danylo Halytsky Lviv National Medical University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2023年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
200
试验地点
1
主要终点
Estimation of the immune activity

研究概览

简要总结

Research concerning women pathogenic microflora during different conditions

详细描述

Study of microflora of different groups of women of reproductive age, determination of pathogens and their further study, samples of a newly synthesized compound on isolated pathogens

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Participant)

入排标准

年龄范围
15 Years 至 49 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • urogenital infections, pregnancy

排除标准

  • healthy microflora

研究组 & 干预措施

Women with bacterial vaginosis

Experimental

Women with bacterial vaginosis (symptomatic or asymptomatic)

干预措施: Microbiological identification kits (ANAEROtest, STAPHYtest, ENTEROtest, NEFERMtest) (Diagnostic Test)

Women with bacterial vaginosis

Experimental

Women with bacterial vaginosis (symptomatic or asymptomatic)

干预措施: Antibiotic therapy after the results of antibiotic sensitivity test (Mostly Oxacillin, Benzylpenicillin, Ceftriaxone, Doxycycline, Clindamycin) (Drug)

Women with bacterial vaginosis

Experimental

Women with bacterial vaginosis (symptomatic or asymptomatic)

干预措施: Suppositoria for vaginal microflora recovery (Giynoflor) (Combination Product)

Women with bacterial vaginosis

Experimental

Women with bacterial vaginosis (symptomatic or asymptomatic)

干预措施: Antifungal therapy (Mostly Fluconazole, Nystatin, Amphotericin B) (Drug)

Pregnant women

Experimental

Pregnant women with different ifections

干预措施: Microbiological identification kits (ANAEROtest, STAPHYtest, ENTEROtest, NEFERMtest) (Diagnostic Test)

Pregnant women

Experimental

Pregnant women with different ifections

干预措施: Antibiotic therapy after the results of antibiotic sensitivity test (Mostly Oxacillin, Benzylpenicillin, Ceftriaxone, Doxycycline, Clindamycin) (Drug)

Pregnant women

Experimental

Pregnant women with different ifections

干预措施: Suppositoria for vaginal microflora recovery (Giynoflor) (Combination Product)

Pregnant women

Experimental

Pregnant women with different ifections

干预措施: Antifungal therapy (Mostly Fluconazole, Nystatin, Amphotericin B) (Drug)

Women with asymptomic infections

Experimental

Women with asymptomic infections of urogenital tract

干预措施: Microbiological identification kits (ANAEROtest, STAPHYtest, ENTEROtest, NEFERMtest) (Diagnostic Test)

Women with asymptomic infections

Experimental

Women with asymptomic infections of urogenital tract

干预措施: Antibiotic therapy after the results of antibiotic sensitivity test (Mostly Oxacillin, Benzylpenicillin, Ceftriaxone, Doxycycline, Clindamycin) (Drug)

Women with asymptomic infections

Experimental

Women with asymptomic infections of urogenital tract

干预措施: Suppositoria for vaginal microflora recovery (Giynoflor) (Combination Product)

结局指标

主要结局

Estimation of the immune activity

时间窗: 1 month

Detection of quantities of different immune cells: lymphocytes, leukocytes, neutrophils, eosinophils

Quantities of vaginal microflore bacteria

时间窗: 2 months

Detection of quantities of vaginal microflore bacteria before and after antibiotic therapy (in TBC)

次要结局

  • Quantities of bacteria in urine(2 months)

研究者

发起方
Danylo Halytsky Lviv National Medical University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验